Mike Rothe

13.7k total citations · 11 hit papers
30 papers, 11.9k citations indexed

About

Mike Rothe is a scholar working on Immunology, Cancer Research and Molecular Biology. According to data from OpenAlex, Mike Rothe has authored 30 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Mike Rothe's work include Immune Response and Inflammation (15 papers), NF-κB Signaling Pathways (15 papers) and interferon and immune responses (6 papers). Mike Rothe is often cited by papers focused on Immune Response and Inflammation (15 papers), NF-κB Signaling Pathways (15 papers) and interferon and immune responses (6 papers). Mike Rothe collaborates with scholars based in United States, Germany and Italy. Mike Rothe's co-authors include David V. Goeddel, Carsten J. Kirschning, Holger Wesche, William J. Henzel, T. Merrill Ayres, Zhaodan Cao, Xiong Gao, Ralf Schwandner, Roman Dziarski and Catherine H. Régnier and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Mike Rothe

30 papers receiving 11.6k citations

Hit Papers

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activat... 1994 2026 2004 2015 1999 1997 1997 1995 1995 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Rothe United States 26 7.1k 5.5k 5.3k 2.1k 1.2k 30 11.9k
Elizabeth B. Kopp United States 15 5.1k 0.7× 3.4k 0.6× 3.5k 0.7× 1.3k 0.6× 963 0.8× 19 9.8k
Marta Muzio Italy 41 6.9k 1.0× 5.7k 1.0× 2.0k 0.4× 1.6k 0.8× 1.5k 1.3× 88 12.2k
Gail A. Bishop United States 54 7.3k 1.0× 3.3k 0.6× 2.5k 0.5× 2.0k 1.0× 1.5k 1.3× 217 11.7k
Claus Scheidereit Germany 66 5.3k 0.7× 7.6k 1.4× 5.4k 1.0× 2.9k 1.4× 801 0.7× 103 14.3k
Wen‐Chen Yeh Canada 39 4.7k 0.7× 5.5k 1.0× 2.9k 0.5× 1.7k 0.8× 1.2k 1.1× 60 10.4k
Mark Boldin United States 32 6.3k 0.9× 10.5k 1.9× 8.7k 1.6× 1.8k 0.8× 1.2k 1.1× 52 16.5k
Michael Kracht Germany 51 3.9k 0.5× 4.7k 0.8× 2.5k 0.5× 1.9k 0.9× 1.1k 0.9× 153 9.7k
Zhaodan Cao United States 18 5.6k 0.8× 3.5k 0.6× 4.6k 0.9× 1.6k 0.8× 553 0.5× 29 8.4k
Jürgen Ruland Germany 65 8.8k 1.2× 8.3k 1.5× 3.4k 0.6× 3.0k 1.5× 2.5k 2.1× 161 17.7k
Amer A. Beg United States 51 8.2k 1.1× 8.0k 1.5× 7.2k 1.4× 3.5k 1.7× 1.4k 1.2× 95 16.4k

Countries citing papers authored by Mike Rothe

Since Specialization
Citations

This map shows the geographic impact of Mike Rothe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Rothe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Rothe more than expected).

Fields of papers citing papers by Mike Rothe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Rothe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Rothe. The network helps show where Mike Rothe may publish in the future.

Co-authorship network of co-authors of Mike Rothe

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Rothe. A scholar is included among the top collaborators of Mike Rothe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Rothe. Mike Rothe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freeman, Daniel J., et al.. (2008). Fully human Anti-HER3 monoclonal antibodies (mAbs) have unique in vitro and in vivo functional and antitumor activities versus other HER family inhibitors. Cancer Research. 68. 19 indexed citations
2.
Treder, Martin, Susanne Hartmann, Eric Borges, et al.. (2008). Fully human Anti-HER3 monoclonal antibodies (mAbs) inhibit oncogenic signaling and tumor cell growth in vitro and in vivo. 68. 14 indexed citations
3.
Abraham, Reimar, Juliane Schäfer, Mike Rothe, et al.. (2005). Identification of MMP-15 as an Anti-apoptotic Factor in Cancer Cells. Journal of Biological Chemistry. 280(40). 34123–34132. 68 indexed citations
4.
Heine, Holger, Carsten J. Kirschning, Egil Lien, et al.. (1999). Cutting Edge: Cells That Carry A Null Allele for Toll-Like Receptor 2 Are Capable of Responding to Endotoxin. The Journal of Immunology. 162(12). 6971–6975. 206 indexed citations
5.
Zhang, Xiao Hui, Carsten J. Kirschning, Xiao-Ping Xu, et al.. (1999). Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes. Journal of Biological Chemistry. 274(12). 7611–7614. 539 indexed citations breakdown →
6.
Schwandner, Ralf, Roman Dziarski, Holger Wesche, Mike Rothe, & Carsten J. Kirschning. (1999). Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2. Journal of Biological Chemistry. 274(25). 17406–17409. 1415 indexed citations breakdown →
7.
Kirschning, Carsten J., Holger Wesche, T. Merrill Ayres, & Mike Rothe. (1998). Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide. The Journal of Experimental Medicine. 188(11). 2091–2097. 653 indexed citations breakdown →
8.
Régnier, Catherine H., Ho Yeong Song, Xiong Gao, et al.. (1997). Identification and Characterization of an IκB Kinase. Cell. 90(2). 373–383. 1055 indexed citations breakdown →
9.
Yeh, Wen-Chen, Arda Shahinian, Daniel E. Speiser, et al.. (1997). Early Lethality, Functional NF-κB Activation, and Increased Sensitivity to TNF-Induced Cell Death in TRAF2-Deficient Mice. Immunity. 7(5). 715–725. 705 indexed citations breakdown →
11.
Takeuchi, Masahiro, Mike Rothe, & David V. Goeddel. (1996). Anatomy of TRAF2. Journal of Biological Chemistry. 271(33). 19935–19942. 272 indexed citations
12.
Rothe, Mike, Jie Xiong, Hong‐Bing Shu, et al.. (1996). I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.. Proceedings of the National Academy of Sciences. 93(16). 8241–8246. 189 indexed citations
13.
Rothe, Mike, et al.. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell. 83(7). 1243–1252. 1030 indexed citations breakdown →
14.
Schindler, Ulrike, et al.. (1995). Components of a stat recognition code: Evidence for two layers of molecular selectivity. Immunity. 2(6). 689–697. 225 indexed citations
15.
Rothe, Mike, Vidya Sarma, Vishva M. Dixit, & David V. Goeddel. (1995). TRAF2-Mediated Activation of NF-κB by TNF Receptor 2 and CD40. Science. 269(5229). 1424–1427. 928 indexed citations breakdown →
16.
Rothe, Mike, et al.. (1994). A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78(4). 681–692. 909 indexed citations breakdown →
17.
Rothe, Mike, Ernst A. Wimmer, Michael J. Pankratz, Marcos González‐Gaitán, & Herbert Jäckle. (1994). Identical transacting factor requirement for knirps and knirps-related gene expression in the anterior but not in the posterior region of the Drosophila embryo. Mechanisms of Development. 46(3). 169–181. 35 indexed citations
18.
Jacobsen, F W, Mike Rothe, David V. Goeddel, et al.. (1994). Role of the 75-kDa tumor necrosis factor receptor: inhibition of early hematopoiesis.. Proceedings of the National Academy of Sciences. 91(22). 10695–10699. 69 indexed citations
19.
Tartaglia, Louis A., et al.. (1993). Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell. 73(2). 213–216. 292 indexed citations
20.
Rothe, Mike, et al.. (1992). Loss of gene function through rapid mitotic cycles in the Drosophila embryo. Nature. 359(6391). 156–159. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026